Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Peptic Ulcer

• Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
• OPEN Versus InTact Capsule Proton Pump Inhibitors for the Treatment of Marginal Ulcers
• Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology
• Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic Ulcer
• PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers
• Prevalence of Marginal Ulcer After PPPD and Preventive Effect of Proton Pump Inhibitor in Korea: A Prospective Multicenter Study
• Precise Delivery of Tranexamic Acid to Enhance Endoscopic Hemostasis for Peptic Ulcer Bleeding
• Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy
• Efficacy of Vonoprazan Versus Intravenous Proton Pump Inhibitors for Prevention of Rebleeding in High Risk Peptic Ulcers Bleeding After Successful Endoscopic Hemostasis
• Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDs
• Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer
• To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children.
• Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
• Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease
• Oral Omeprazole in Bleeding Peptic Ulcer
• Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis
• BE Study of Gaster®D Tab 20mg (Manufacturer Changed)
• Efficacy of Low Dose Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding
• Platelet Rich Plasma in Bleeding Peptic Ulcer
• Prevention of Recurrent Ulcer Bleeding in Patients With Idiopathic Gastroduodenal Ulcer
• Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
• IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
• Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases
• Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection
• Proton Pump Inhibitor Prevent Dual Antiplatelet Agents Induced Gastrointestinal Ulcer After Coronary Artery Bypass Graft
• UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD
• Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
• Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents
• Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding
• The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients
• Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy
• The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers
• Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers
• Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot
• Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients
• Doppler-guided Endoscopic Treatment in Peptic Ulcer Bleeding
• Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer
• Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users
• Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy
• DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers
• The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers
• Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication
• Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
• Cytoprotective Agent and Peptic Ulcer in Dual Antiplatelet :RCT
• Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment
• Risk of Uncomplicated Peptic Ulcer in the General Population
• The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With Hypoalbuminemia
• High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer
• Empirical Rescue Therapies of Helicobacter Pylori Infection
• Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment
• Aizthromycin or Clarithromycin in H-pylori Eradication Regimen
• Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori
• The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers
• Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers
• Antibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical Procedures
• A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers
• Oral Versus IV Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Endoscopic Hemostasis
• PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers
• Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy
• Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer
• Oral vs Intravenous and Proton Pump Inhibitor (PPI）for Peptic Ulcer Bleeding (PUB)
• Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets
• Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately
• Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately
• Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding
• Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor
• Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion
• Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers
• Effect of Naproxen, Aspirin, Celecoxib, or Clopidogrel on the Healing of Stomach and Intestinal Ulcers
• Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding
• High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic Treatment
• Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers
• Ulcer Prevention Study in Post Gastric Bypass Patients
• Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic Ulcers
• Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer
• Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers
• Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)
• High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding
• AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers
• Effects of 2 Different Doses of Pantoprazole on Gastric pH and Recurrent Bleeding in Patients Who Bled From Peptic Ulcers
• Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)
• A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer
• Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer
• A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin
• A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer
• Administration of High-Dose Intravenous Proton Pump Inhibitor for Upper Gastrointestinal Bleeding Prior to Endoscopy
• The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships
• On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication
• Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding
• Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population
• Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
• Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage